Lexeo Therapeutics, Inc. (LXEO)

Lexeo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	174.98	121.47	77.34	135.86	29.37
Cash & Short-Term Investments	174.98	121.47	77.34	135.86	29.37
Cash Growth	284.24%	57.06%	-43.08%	362.53%	-
Prepaid Expenses	2.17	2.83	2.34	0.13	-
Other Current Assets	-	0	0.37	0.7	0.03
Total Current Assets	177.15	124.29	80.05	136.68	29.41
Property, Plant & Equipment	11.61	12.26	13.78	0.17	-
Other Long-Term Assets	3.25	3.25	3.25	0	0
Total Assets	192.01	139.81	97.08	136.86	29.41
Accounts Payable	5.77	3.79	2.68	3.06	0.04
Accrued Expenses	10.22	10.51	8.09	3.78	0.25
Current Portion of Leases	2.67	2.61	2.83	-	-
Current Income Taxes Payable	0.04	0.16	0.51	0.53	0.04
Current Unearned Revenue	-	-	-	0.05	0.14
Other Current Liabilities	0.18	0.17	0.24	0.03	0.22
Total Current Liabilities	18.88	17.24	14.35	7.45	0.7
Long-Term Leases	8.18	9.03	10.65	-	-
Other Long-Term Liabilities	-	-	-	-	3.01
Total Liabilities	27.06	26.27	25	7.45	3.71
Common Stock	0	0	-	0	0
Additional Paid-In Capital	389.72	295.37	2.49	0.57	0.01
Retained Earnings	-224.76	-181.84	-115.45	-56.17	-5.55
Total Common Equity	164.95	113.54	-112.95	-55.6	-5.54
Shareholders' Equity	164.95	113.54	72.08	129.41	25.7
Total Liabilities & Equity	192.01	139.81	97.08	136.86	29.41
Total Debt	10.85	11.64	13.48	-	-
Net Cash (Debt)	164.13	109.83	63.85	135.86	29.37
Net Cash Growth	399.16%	72.00%	-53.00%	362.53%	-
Net Cash Per Share	8.29	20.51	39.17	87.50	20.38
Filing Date Shares Outstanding	33.06	26.65	1.61	1.58	1.51
Total Common Shares Outstanding	33.04	26.65	1.61	1.58	1.51
Working Capital	158.27	107.06	65.7	129.24	28.71
Book Value Per Share	4.99	4.26	-70.28	-35.18	-3.66
Tangible Book Value	164.95	113.54	-112.95	-55.6	-5.54
Tangible Book Value Per Share	4.99	4.26	-70.28	-35.18	-3.66
Machinery	1.16	0.89	0.65	0.19	-
Leasehold Improvements	0.27	0.25	0.23	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.